Foghorn Therapeutics (FHTX) Shares Outstanding (Diluted) (2020 - 2026)
Foghorn Therapeutics (FHTX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 10.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 680.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | 69.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.54 Mn |
| Dec 31, 2025 | 62.98 Mn |
| Sep 30, 2025 | 63.03 Mn |
| Jun 30, 2025 | 62.98 Mn |
| Mar 31, 2025 | 62.85 Mn |
| Dec 31, 2024 | 54.90 Mn |
| Sep 30, 2024 | 62.60 Mn |
| Jun 30, 2024 | 51.58 Mn |
| Mar 31, 2024 | 42.43 Mn |
| Dec 31, 2023 | 41.97 Mn |
| Sep 30, 2023 | 42.03 Mn |
| Jun 30, 2023 | 41.83 Mn |
| Mar 31, 2023 | 41.81 Mn |
| Dec 31, 2022 | 41.59 Mn |
| Sep 30, 2022 | 41.67 Mn |
| Jun 30, 2022 | 41.52 Mn |
| Mar 31, 2022 | 41.37 Mn |
| Dec 31, 2021 | 37.17 Mn |
| Sep 30, 2021 | 36.97 Mn |
| Jun 30, 2021 | 36.85 Mn |